S-phase fraction related to prognosis in localised prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1

International Journal of Cancer

Volumn 79, Issue 6, 1998, Pages 553-559

  Åström, Lennart ^a   Weimarck, Anna ^a   Aldenborg, Frank ^a   Delle, Ulla ^a   Hanson, Charles ^a   Verbiene, Ingrida ^a   Danielsson, Anna ^a   Hammarsten, Jan ^b   Köpf, Istvan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b VARBERG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER GENETICS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CHROMOSOME 7; CHROMOSOME DELETION; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

EID: 0031771576     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981218)79:6<553::AID-IJC1>3.0.CO;2-S     Document Type: Article

References (38)

1. ADOLFSSON, J., Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results. Int. J. Cancer, 58, 211-216 (1994).
2. ADOLFSSON, J., RONSTROM, L., CARSTENSEN, J., LOWHAGEN, T. and HEDLUND, P.O., The natural course of low grade, non-metastatic prostatic carcinoma. Brit. J. Urol., 65, 611-614 (1990).
3. ALCARAZ, A., TAKAHASHI, S., BROWN, J.A., HERATH, J.F., BERGSTRALH, E.J., LARSON KELLER, J.J., LIEBER, M.M. and JENKINS, R.B., Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res., 54, 3998-4002 (1994).
4. ALY, M.S., CIN, P.D., VAN DE VOORDE, W., VAN POPPEL, H., AMEYE, F., BAERT, L. and VAN DEN BERGHE, H., Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosomes Cancer, 9, 227-233 (1994).
5. BABU, V.R., MILES, B.J., CERNG, J.C., WEISS, L. AND VAN DYKE, D.L., Cytogenetic study of four cancers of the prostate. Cancer Genet. Cytogenet., 48, 83-87 (1990).
6. BORGHEDE, G., ALDENBORG, F., WURZINGER, E., JOHANSSON, K.-A. and HEDELIN, H., Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy. Brit. J. Urol., 80, 247-255 (1997).
7. BOVA, G.S. and ISAACS, W.B., Review of allelic loss and gain in prostate cancer. World J. Urol., 14, 338-346 (1996).
8. BRATT, O., ANDERSON, H., BAK JENSEN, E., BALDETORP, B. and LUNDGREN, R., Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis. Urology, 47, 218-224 (1996).
9. BROWN, J.A., ALCARAZ, A., TAKAHASHI, S., PERSONS, D.L., LIEBER, M.M. and JENKINS, R.B., Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma [see comments]. J. Urol., 152, 1157-1162 (1994).
10. CHER, M.L., BOVA, G.S., MOORE, D.H., SMALL, E.J., CARROLL, P.R., PIN, S.S., EPSTEIN, J.I., ISAACS, W.B. and JENSEN, R.H., Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56, 3091-3102 (1996).
11. CHER, M.L., ITO, T., WEIDNER, N., CARROLL, P.R. and JENSEN, R.H., Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J. Urol., 153, 249-254 (1995).
12. CHER, M.L., LEWIS, P.E., BANERJEE, M., HURLEY, P.M., SAKR, W., GRIGNON, D.J. and POWELL, I.J., A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans. Clin. Cancer Res., 4, 1273-1278 (1998).
13. CUNNINGHAM, J.M., SHAN, A., WICK, M.J., MCDONNELL, S.K., SCHAID, D.J., TESTER, D.J., QIAN, J., TAKAHASHI, S., JENKINS, R.B., BOSTWICK, D.G. and THIBODEAU, S.N., Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res., 56, 4475-4482 (1996).
14. GLEASON, D.F., Histologic grading and clinical staging of prostatic carcinoma. In: M. Tannenbaum (ed.), Urologic pathology: the prostate, p. 171, Lea and Febiger, Philadelphia (1977).
15. HOPMAN, A.H.. RAMAEKERS, F.C., RAAP, A.K., BECK, J.L., DEVILEE, P., VAN DER PLOEG, M. and VOOIJS, G.P., In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry, 89, 307-316 (1988).
16. HUANG, S.F., XIAO, S., RENSHAW, A.A., LOUGHLIN, K.R., HUDSON, T.J. and FLETCHER, J.A., Fluorescence in situ hybridization evaluation of cdhromosome deletion patterns in prostate cancer. Amer. J. Pathol., 149, 1565-1573 (1996).
17. JENKINS, R.B., QIAN, J., LEE, H.K., HUANG, H. HIRASAWA, K., BOSTWICK, D.G., PROFFITT, J., WILBER, K., LIEBER, M.M., LIU, W. and SMITH, D.I., A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res., 58, 759-766 (1998).
18. JOHANSSON, B., HEIM, S., MANDAHL, N., MERTENS, F. and MITELMAN, F., Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer, 6, 199-205 (1993).
19. KALLIONIEMI, O.P., VISAKORPI, T., HOLLI, K., HEIKKINEN, A., ISOLA, J. and KOIVULA, T., Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry, 12, 413-421 (1991).
20. KÖPF, I., HANSON, C., DELLE, U., VERBIENE, I. and WEIMARCK, A., A rapid and simplified technique for analysis of archival formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization (FISH). Anticancer Res., 16, 2533-2536 (1996)
21. KUNIMI, K., BERGERHEIM, U.S., LARSSON, I.L., EKMAN, P. and COLLINS. V.P., Allelotyping of human prostatic adenocarcinoma. Genomics, 11, 530-536 (1991).
22. LEE, S.E., CURRIN, S.M., PAULSON, D.F. and WALTHER, P.J., Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. J. Urol., 140, 769-774 (1988).
23. MACOSKA, J.A., TRYBUS, T.M., SAKR, W.A., WOLF, M.C., BENSON, P.D., POWELL, I.J. and PONTES, J.E., Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res., 54, 3824-3830 (1994).
24. MATSUYAMA, H., PAN, Y., SKOOG, L., TRIBUKAIT, B., NAITO, K., EKMAN, P., LICHTER, R and BERGERHEIM. U.S., Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene, 9, 3071-3076 (1994).
25. MITELMAN, F., JOHANSSON, B., MANDAHL, N. and MERTENS, F., Clinical significance of cytogenetic findings in solid tumors. Cancer Genet. Cytogenet., 95, 1-8 (1997a).
26. MITELMAN, F., MERTENS, F. and JOHANSSON, B., A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature (Genet.), 15 (Special issue), 417-474 (1997b).
27. NILBERT, M., HEIM, S., MANDAHL, N., FLODERUS, U.M., WILLEN, H. and MITELMAN, F., Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum. Genet., 85, 605-611 (1990).
28. POLLACK, A., ZAGARS, G.K., EL NAGGAR, A.K., GAUWITZ, M.D. and TERRY, N.H., Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer, 73, 1895-1903 (1994).
29. SCHRÖDER, F., TRIBUKAIT, B., BOCKING, A., DEVERE WHITE, R., KOSS, L., LIEBER, M., STENKVIST, B. and ZETTERBERG, A., Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus conference on diagnosis and prognostic parameters in located prostate cancer. Scand. J. Urol. Nephrol. (Suppl.), 162, 51-63 (1994).
30. SHANKEY, T.V., KALLIONIEMI, O.P., KOSLOWSKI, J.M., LIEBER, M.L., MAYALL, B.H., MILLER, G. and SMITH, G.J., Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry, 14, 497-500 (1993).
31. TAKAHASHI, S., SHAN, A.L., RITLAND, S.R., DELACEY, K.A., BOSTWICK, D.G., LIEBER, M.M., THIBODEAU, S.N. and JENKINS, R.B., Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55, 4114-4119 (1995).
32. TAVARES, A.S., COSTA, J., CARVALHO, A.D. and REIS, M., Tumour ploidy and prognosis in carcinomas of the bladder and prostate. Brit. J. Cancer, 20, 38-441 (1966).
33. VESALAINEN, S., LIPPONEN, P., TALJA, M. and SYRJANEN, K., Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Europ. J. Cancer, 30a, 1797-1803 (1994).
34. VISAKORPI, T., HYYTINEN, E., KALLIONIEMI, A., ISOLA, J. and KALLIONIEMI, O.P., Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Amer. J. Pathol., 145, 624-630 (1994).
35. VISAKORPI, T., KALLIONIEMI, O.P., PARONEN, I.Y., ISOLA, J.J., HEIKKINEN, A.L and KOIVULA, T.A., Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy. Brit. J. Cancer, 64, 578-582 (1991).
36. WANG, R.Y., TRONCOSO, P., PALMER, J.L., EL-NAGGAR, A.K. and LIANG, J.C., Trisomy 7 by dual color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression. Clin. Cancer Res., 2, 1553-1558 (1996).
37. ZENKLUSEN, J.C., THOMPSON, J.C., TRONCOSO, P., KAGAN, J. and CONTI, C.J., Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res., 54, 6370-6373 (1994).
38. ZITZELSBERGER, H., SZUCS, S., ROBENS, E., WEIER, H.U., HOFLER, H. and BAUCHINGER, M., Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinomas. Cancer Genet. Cytogenet., 90, 37-44 (1996).